Suppr超能文献

阿尔茨海默病中的内体溶酶体功能障碍:发病机制和治疗干预。

Endosomal-lysosomal dysfunctions in Alzheimer's disease: Pathogenesis and therapeutic interventions.

机构信息

School of Health Science, International Medical University, 57000, Kuala Lumpur, Malaysia.

School of Pharmacy, Monash University Malaysia, 47500, Selangor, Malaysia.

出版信息

Metab Brain Dis. 2021 Aug;36(6):1087-1100. doi: 10.1007/s11011-021-00737-0. Epub 2021 Apr 21.

Abstract

The endosomal-lysosomal system mediates the process of protein degradation through endocytic pathway. This system consists of early endosomes, late endosomes, recycling endosomes and lysosomes. Each component in the endosomal-lysosomal system plays individual crucial role and they work concordantly to ensure protein degradation can be carried out functionally. Dysregulation in the endosomal-lysosomal system can contribute to the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD). In AD endosomal-lysosomal abnormalities are the earliest pathological features to note and hence it is important to understand the involvement of endosomal-lysosomal dysfunction in the pathogenesis of AD. In-depth understanding of this dysfunction can allow development of new therapeutic intervention to prevent and treat AD.

摘要

内体溶酶体系统通过内吞途径介导蛋白质降解过程。该系统由早期内体、晚期内体、再循环内体和溶酶体组成。内体溶酶体系统中的每个组成部分都发挥着各自关键的作用,它们协同工作以确保蛋白质降解能够正常进行。内体溶酶体系统的失调可能导致神经退行性疾病(如阿尔茨海默病)的发病机制。在 AD 中,内体溶酶体异常是最早注意到的病理特征,因此了解内体溶酶体功能障碍在 AD 发病机制中的作用非常重要。深入了解这种功能障碍可以为预防和治疗 AD 开发新的治疗干预措施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验